maxgraft® cortico

Allogenic cortical bone plate

The proper size of the plate is estimated after the elevation of the mucosal flap or preoperatively using a digital planning software. Using a diamond disc, the plate is then cut extraorally. The plate is positioned within a certain distance by predrilling through the plate and local bone; fixation is performed with osteosynthesis screws to create a fixed compartment. To prevent the perforation of the soft tissue, the sharp edges have to be removed, e.g. by using a diamond ball.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Defect filling

To fascilitate osteosynthesis, allogenic particles (e.g. maxgraft®) can be used to fill the defect. The preserved human collagen provides excellent osteoconductivity and enables complete remodelling. Mixing with autologous chips or particulated PRF-matrizes can support the ossification.

Augmentation with maxgraft® cortico - Dr. K. Chmielewski

Preparation of a single tooth defect with severely resorbed vestibular wall

Three-dimensional augmentation with maxgraft® cortico - M.Sc. E. Kapogianni

Initial clinical situation – missing bonein regio 11, 12, 21, 22 and scarred soft tissue

Horizontal ridge augmentation with maxgraft® cortico - M.Sc. E. Kapogianni

OPG of the initial situation – provision of missing denture in regio 44 to 47 by a resin-retained bridge

Please Contact us for Literature.

maxgraft® cortico animation
maxgraft® cortico animation
Shell technique with maxgraft® cortico - live surgery by Dr. Jan Kielhorn
Shell technique with maxgraft® cortico - live surgery by Dr. Jan Kielhorn
Handling maxgraft® cortico
Handling maxgraft® cortico

maxgraft® granules

Processed allograft

For experienced oral and maxillofacial surgeons, allograft bone is  the only real alternative to harvesting the patient’s own autologous bone. This helps preventing well known risks such as donor-site morbidity, infection, post-operative pain, and bone-stability loss. The excellent biological regeneration capability of maxgraft® results in a predictable clinical outcome.

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Rehydration

The processing of maxgraft® products preserves the natural collagen content of the bone tissue and a residual moisture of ~5%. Thus, the products don‘t have to be re-hydrated but are ready for instant use. Nevertheless, rehydration in blood from the defect site or saline solution can facilitate handling and application of granules since the wetted maxgraft® granules stick together. Be aware that hyper-hydration can result in the loss of structural integrity!

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

[1] Tilaveridis I. et al, The use of mineralized bone allograft (C+TBA) as a single grafting material in maxillary sinus lifting with severely atrophied alveolar ridge (1–3mm) and immediately inserted dental implants. A 3- up to 8-year retrospective study, 2018 Oral and Maxillofacial Surgery, Sep;22(3):267-273.
[2] Simonpieri A. et al. Four-year post-loading results of full-arch rehabilitation with immediate placement and immediate loading implants: A retrospective controlled study. Quintessence Int. 2017;48(4):315-324.
C+TBA Allografts: Presenting the Allotec® process
C+TBA Allografts: Presenting the Allotec® process

maxgraft® bonering

One-stage bone augmentation and implantation

Compared to the classical two-stage augmentation with bone blocks, this technique reduces the entire treatment period by several months and saves the re-entry. maxgraft® bonering is suitable for vertical and horizontal augmentation and promotes new bone formation, therefore simplifying the surgical treatment. With the maxgraft® bonerig surgical kit, botiss biomaterials provides all necessary instruments to apply the maxgraft® bonering technique. The kit includes two convenient sizes of trephines, which precisely match the maxgraft® bonering diameters.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Graft exposure

Wound dehiscence and graft exposure can be common complications of augmentation. After removal of necrotic soft tissue and infected hard tissue (use rotating instruments if necessary) the augmented area should be rinsed with chlorhexidine. Subsequently, the graft has to be covered again, if necessary, by harvesting a palatal soft tissue transplant.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Wound closure

Carefully consider the soft tissue situation prior to surgical intervention! Please keep in mind that a tension-free closure of the flap is essential for the success of the procedure.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Rehydration

maxgraft® bonerings do not need to be rehydrated. Preparation of the ring bed using the maxgraft® bonering surgical kit ensures close contact of the bone ring to vital bleeding bone, enabling fast bony integration of implant and bone graft.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Re-entry

Once maxgraft® bonering is fixed with a suitable implant, it provides great primary stability. Implant loading should be performed 6 months after transplantation to avoid resorption of the bone graft caused by a lack of mechanical stimulus.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Combination with cerabone®

The combination of maxgraft® bonering with a xenogenic material (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® bonering induces fast incorporation of graft and implant, the volume-stable cerabone® acts as a barrier against resorption and improves the esthetic outcome.

Graft exposure

Wound dehiscence and graft exposure can be common complications of augmentation. After removal of necrotic soft tissue and infected hard tissue (use rotating instruments if necessary) the augmented area should be rinsed with chlorhexidine. Subsequently, the graft has to be covered again, if necessary, by harvesting a palatal soft tissue transplant.

Graft exposure

Wound dehiscence and graft exposure can be common complications of augmentation. After removal of necrotic soft tissue and infected hard tissue (use rotating instruments if necessary) the augmented area should be rinsed with chlorhexidine. Subsequently, the graft has to be covered again, if necessary, by harvesting a palatal soft tissue transplant.

Graft exposure

Wound dehiscence and graft exposure can be common complications of augmentation. After removal of necrotic soft tissue and infected hard tissue (use rotating instruments if necessary) the augmented area should be rinsed with chlorhexidine. Subsequently, the graft has to be covered again, if necessary, by harvesting a palatal soft tissue transplant.

Graft exposure

Wound dehiscence and graft exposure can be common complications of augmentation. After removal of necrotic soft tissue and infected hard tissue (use rotating instruments if necessary) the augmented area should be rinsed with chlorhexidine. Subsequently, the graft has to be covered again, if necessary, by harvesting a palatal soft tissue transplant.

Graft exposure

Wound dehiscence and graft exposure can be common complications of augmentation. After removal of necrotic soft tissue and infected hard tissue (use rotating instruments if necessary) the augmented area should be rinsed with chlorhexidine. Subsequently, the graft has to be covered again, if necessary, by harvesting a palatal soft tissue transplant.

Vertical augmentation and sinus lift with maxgraft® bonering - Dr. O. Yüksel and Dr. B. Giesenhagen

Vertical augmentation: Preparation of ring bed in atrophic mandibula (third quadrant)

Restoration of all four incisors with two maxgraft® bonering - Dr. B Giesenhagen

Initial situation pre-op: Central incisors with mobility 3

Periimplantitis treatment with maxgraft® bonering - Dr. B. Giesenhagen

Severe periimplantitis at tooth 15 with bone loss up to 1/3 of the implant

Sinus Floor Elevation with maxgraft® bonering and subcrestal implantation in an eggshell thin sinus - Dr. K. Chmielewski

Initial situation: X-ray scan reveals eggshell thin sinus floor (1-3 mm) on both sites of the maxilla; green areas indicate the planned maxgraft® bonerings and red areas the planned implants

bone augmentation in the aesthetic zone with maxgraft® bonering -Dr. R. Cutts

Clinical situation: 71-old patient with atrial fibrillation and Warfarin medication

Advanced vertical augmentation in posterior maxilla with maxgraft® bonering - Dr. A. Isser

Initial situation 57-year old female patient. X-ray scan reveals severe bone loss due to inflammation in region 13. Treatment plan was extraction of teeth 13 and 14 and augmentation after healing.

Augmentation of buccal and lingual bone lamella with maxgraft® bonering - Dr. B. Giesenhagen

X-ray scan: initial situation loss of two wall bony defect with loss of buccal and lingual lamella

Restoration of buccal layer with maxgraft® bonering - A. Patel

Initial situation: missing incisor with loss of buccal wall

Guided bone ring procedure in aesthetic zone - Dr. K. Chmielewski & Dr. O. Yükse

Planning the surgery with CoDiagnstix® for Straumann® Guided Surgery

Sinus Floor Elevation with maxgraft® bonering - Dr. B. Giesenhagen

X-ray scan reveals initial situation with maxillary bone height in regio 15 of 1.5 mm

Restoration of buccal bone lamella in aesthetic zone with maxgraft® bonering - Dr. A. Patel

Initial situation: bone loss due to lack of physical load of bridge retained region 11

[1] Flanagan D. (2016). Cylindrical Ringbone Allograft to Restore Atrophic Implant Sites: A Pilot Study. Journal of Oral Implantology 2016;42(2):159-163.
[2] Miller at el. (2017). Use of the Straumann® AlloGraft Ring With Simultaneous Implant Placement: A Novel Approach. Compendium of Continuing Education in Dentistry Nov/Dec 2017, Vol 38, Issue 11 https://www.aegisdentalnetwork.com/cced/2017/11/use-of-the-straumann-allograft-ring-with-simultaneous-implant-placement-a-novel-approach
[3] Giesenhagen G, Martin N, Donkiewicz P, Kacarević ZP, Smeets R, Jung O, Schnettler R, Barbeck M (2018). Vertical bone augmentation in a single-tooth gap with an allogenic bone ring: Clinical considerations. J Esthet Restor Dent. 2018;1–4. https://doi.org/10.1111/jerd.12392
[4] Benlidayi E, Salimov F, Tukel C, Yüksel O (2018). Comparison of autogenous and allograft bone rings in surgically created vertical bone defects around implants in a sheep model. Clin Oral Implants Res. 2018. https://www.ncbi.nlm.nih.gov/m/pubmed/30281857/
[5] Giesenhagen B, Martin N, Jung O, Barbeck M (2019). Bone Augmentation and Simultaneous Implant Placement with Allogenic Bone Rings and Analysis of Its Purification Success. Materials 2019 9 12, 1291; https://doi.org/10.3390/ma12081291
maxgraft® bonering technique animation
maxgraft® bonering technique animation
Live OP vertikale Augmentation mit maxgraft® bonering Dr. A. Vossenberg
Live OP vertikale Augmentation mit maxgraft® bonering Dr. A. Vossenberg
Bone Ring Technique surgery performed by Dr. Orcan Yüksel and Dr. Kris Chmielewski
Bone Ring Technique surgery performed by Dr. Orcan Yüksel and Dr. Kris Chmielewski
Live-surgery maxgraft® bonering Dr. Bernhard Giesenhagen
Live-surgery maxgraft® bonering Dr. Bernhard Giesenhagen
Live surgery maxgraft® bonering Dr. Bernhard Giesenhagen
Live surgery maxgraft® bonering Dr. Bernhard Giesenhagen
maxgaft® bonering surgery David Furze
maxgaft® bonering surgery David Furze
Live surgery maxgraft® bonering Dr. Bernhard Giesenhagen & Dr. Orcan Yüksel
Live surgery maxgraft® bonering Dr. Bernhard Giesenhagen & Dr. Orcan Yüksel
Dr. Orcan Yüksel about the maxgraft® bonering
Dr. Orcan Yüksel about the maxgraft® bonering
maxgraft® bonering surgery by Dr. Bernhard Giesenhagen
maxgraft® bonering surgery by Dr. Bernhard Giesenhagen

maxgraft® bonebuilder

Patient customized allogenic bone block

The botiss biomaterials partner Cells+Tissuebank Austria (C+TBA) receives a *.stl milling file and the customized allogenic bone block is produced under clean room conditions. maxgraft® bonebuilder may be  applied directly onto the defect. After placement, the maxgraft® bonebuilder block is fixed with osteosynthesis screws. Any residual defect volume should be filled with bone substitute material and the augmentation site covered with a barrier membrane for guided bone regeneration.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Rehydration

maxgraft® bonebuilder should be rehydrated by creating a vaccum in a disposable syringe filled with sterile saline solution, or if possible with the exudate obtained from preparing autologous platelet-rich fibrin (PRF) matrices. maxgraft® bonebuilder consists of a mineralized collagen matrix with a residual moisture content of <5%, rehydration may be useful especially for blocks of bigger and complex dimensions to enhance the adaptability of the material to the specific defect site.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Combination with cerabone® or maxgraft®

Additional void volume should be filled with particulate grafting material (cerabone® or maxgraft®) to improve the esthetic outcome and to protect the soft tissue.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Guided Bone Regeneration

maxgraft® bonebuilder should be covered by a resorbable barrier forming collagen membrane for GBR (guided bone regeneration)- e.g. Jason® membrane - to prevent ingrowth of soft tissue into the bone graft.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Re-entry

Depending on the defect size, the graft will be stably incorporated within approximately 6 months.

Ridge augmentation in the maxilla with maxgraft® bonebuilder in the aesthetic zone - Dr. M. Kristensen

Bone defect in area 11-21 due to two lost implants (periimplantitis) after 15 years of function

Ridge augmentation with maxgraft® bonebuilder and sinus floor elevation – Dr. K.P. Schiechl

Initial clinical situation: Bone defect in the upper right maxilla (teeth #14-16)

Restoration of all four incisors with maxgraft® bonebuilder - Dr. Dr. Dr. Oliver Blume

Pre-operative clinical situation - changed color in the gingiva in the front maxilla

Please Contact us for Literature.

maxgraft® bonebuilder animation
maxgraft® bonebuilder animation
Bone augmentation in the mandible with maxgraft® bonebuilder – Surgery by Dr. David Furze
Bone augmentation in the mandible with maxgraft® bonebuilder – Surgery by Dr. David Furze
maxgraft® bonebuilder in the mandible including incisions by Dr Dr O Blume
maxgraft® bonebuilder in the mandible including incisions by Dr Dr O Blume
Dr. Oliver Blume about the maxgraft® bonebuilder
Dr. Oliver Blume about the maxgraft® bonebuilder
Semi-pillar incisions according to Dr Dr O Blume - maxgraft® bonebuilder
Semi-pillar incisions according to Dr Dr O Blume - maxgraft® bonebuilder
Bone augmentation in the maxilla with maxgraft® bonebuilder - Surgery by Dr. Michael Kristensen
Bone augmentation in the maxilla with maxgraft® bonebuilder - Surgery by Dr. Michael Kristensen